| Not Yet Recruiting | Study to Evaluate HM15275 in Subjects With Type 2 Diabetes Mellitus NCT07527650 | Hanmi Pharmaceutical Company Limited | Phase 2 |
| Not Yet Recruiting | Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes NCT07521475 | Insulet Corporation | N/A |
| Not Yet Recruiting | POLUS: Description of the Effectiveness and Tolerability of Luseogliflozin in Patients With Type 2 Diabetes. NCT07433192 | Servier Russia | — |
| Recruiting | A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Di NCT07351058 | Hoffmann-La Roche | Phase 3 |
| Not Yet Recruiting | Safety and Effectiveness of Tirzepatide in Patients With Obesity at Hospital de Clínicas, Paraguay NCT07492563 | LABORATORIOS INDUFAR | — |
| Not Yet Recruiting | Blended Resources for Integrated Diabetes Guidance and Empowerment NCT07373379 | Peking University | N/A |
| Recruiting | GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes NCT07228117 | Medtronic MiniMed, Inc. | N/A |
| Recruiting | Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus NCT07373938 | Cardenal Herrera University | — |
| Recruiting | A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Partici NCT07433062 | AstraZeneca | Phase 1 |
| Enrolling By Invitation | Metformin, Empagliflozin With Sitagliptin vs Linagliptin in Type 2 Diabetes NCT07452913 | Bahria University | Phase 4 |
| Not Yet Recruiting | Dual vs Triple Lipid-Lowering Therapy in Type 2 Diabetes Mellitus Patients With Elevated LDL Cholesterol NCT07255820 | Bahria University | Phase 4 |
| Not Yet Recruiting | A U.S. Pilot Human Investigation of RadiofrEquency Vapor Ablation System to Evaluate Safety, TOleRability, and NCT07355270 | Aqua Medical, Inc. | N/A |
| Not Yet Recruiting | STUDIIO-Diabetes Pilot: STUdy of Drug Insurance to Improve Outcomes of Diabetes NCT03804905 | Sunnybrook Health Sciences Centre | N/A |
| Not Yet Recruiting | A Phase 3 Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus. NCT06731075 | Oramed, Ltd. | Phase 3 |
| Active Not Recruiting | An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes NCT07276776 | Insulet Corporation | N/A |
| Withdrawn | Lifestyle MIND- Feasibility of Wait-list Control NCT06384521 | The University of Texas Health Science Center at San Antonio | N/A |
| Recruiting | An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People Wit NCT07232537 | Bayer | — |
| Recruiting | The GRoceries Aimed at Increasing Nutrition Study NCT07167004 | University of Pennsylvania | N/A |
| Not Yet Recruiting | Continued Access to the Endogenex System for Participants in the ReCET Pivotal Study NCT07197788 | Endogenex, Inc. | N/A |
| Active Not Recruiting | A Study to Evaluate the Effect of RO7204239 on Insulin Sensitivity and Muscle Composition in Participants With NCT07137585 | Hoffmann-La Roche | Phase 1 |
| Not Yet Recruiting | "Ultrasound-Enhanced Propolis Therapy for Healing Diabetic Foot Wounds" NCT07099482 | Sinai University | N/A |
| Completed | Generative AI-Based Simulation for Diagnostic Communication in Type 2 Diabetes (DIALOGUE-DM2) NCT07252193 | Universidad Nacional Autonoma de Mexico | N/A |
| Active Not Recruiting | An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in Indian People With NCT06763146 | Bayer | — |
| Not Yet Recruiting | GlucoBites Cookies (Gynura Procumbens) for Glycemic Control and Prevention of Diabetic Foot Ulcer Risk in Type NCT07151833 | Andina Setyawati | N/A |
| Not Yet Recruiting | Mesenchymal Stromal/Stem Cells-Derived Exosomes (MSC-Exos) Therapy for Type 2 Diabetes Mellitus Patients NCT07144241 | Indonesia University | Phase 2 |
| Active Not Recruiting | A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes NCT07112872 | Hoffmann-La Roche | Phase 2 |
| Recruiting | A Study to Evaluate the Effect of Maridebart Cafraglutide on Insulin Sensitivity and β-cell Function in Partic NCT07160257 | Amgen | Phase 1 |
| Completed | Simplified Onboarding in Adults With Type 2 Diabetes NCT07070830 | Insulet Corporation | N/A |
| Active Not Recruiting | A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or NCT07018453 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | An Observational Study Called FIRST-2.0 China to Learn More About the Use of the Study Treatment Finerenone In NCT07124039 | Bayer | — |
| Recruiting | Preventing Type 2 Diabetes in Black Emergent Adult NCT06848244 | University of North Carolina, Chapel Hill | N/A |
| Active Not Recruiting | A Study to Investigate the Response of Participants With Type 2 Diabetes Mellitus on Once-Weekly Retatrutide t NCT06982846 | Eli Lilly and Company | Phase 1 |
| Completed | Feasibility and Preliminary Efficacy of a Theory-driven BALANCE Dietary Program Among Patients With Type 2 Dia NCT07472855 | Capital Medical University | N/A |
| Not Yet Recruiting | Peer-Supported Diabetes Self-Care Intervention to Improve Health Related Quality of Life (HRQoL) and Diabetes NCT05637437 | Universiti Putra Malaysia | N/A |
| Not Yet Recruiting | Effect of a Protein-Creatine-Omega3-Vitamin D Supplement on Glycemic Variability in Mexican Patients With Type NCT06920667 | Héctor Iván Saldívar Cerón | N/A |
| Withdrawn | SYNERGY PLUS: Evaluation of Next Generation Sensors (NGS) and Algorithm in Patients With Type 1 and Type 2 Dia NCT06719531 | Medtronic MiniMed, Inc. | N/A |
| Completed | Mass Balance Study of [14C]HRS9531 in Healthy Male Subjects NCT06855147 | Fujian Shengdi Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Clinical Study to Evaluate the Impact of the Accu-Chek SmartGuide CGM Solution on the Mean Change in Time in R NCT06704672 | Hoffmann-La Roche | N/A |
| Completed | CAPTIVATE India - A Study to Assess the Prevalence of Cardiovascular Disease (CVD) in Individuals With Type 2 NCT07121114 | Novo Nordisk A/S | — |
| Completed | Validity And Reliability of The Incremental Shuttle Walk Test In Type 2 Diabetes Mellitus NCT06519318 | Ilayda Kayapinar | — |
| Completed | Lifestyle Intervention and Its Effects on Inflammatory Cytokines and Oxidative Stress Markers in Diabetic Chro NCT07119892 | Sinai University | N/A |
| Completed | A Clinical Study of Mass Balance of [14C]HRS-7535 NCT06819488 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Completed | Feasibility Of Individualized Dietary Plan (Idp) On Glycemic Control And Total Cholestrol In Diabetic Patients NCT07030543 | Khyber Medical University Peshawar | N/A |
| Recruiting | Antidiabetic Effect of Olive Pomace Oil NCT06723886 | Instituto de Ciencia y Tecnología de Alimentos y Nutrición | N/A |
| Completed | Glimepiride, Empagliflozin, and Sitagliptin With Metformin for Type 2 Diabetes NCT06759922 | Bahria University | Phase 4 |
| Not Yet Recruiting | Henagliflozin on Liver Fibrosis in Patients with MASLD and T2DM NCT06762223 | Xiqiao Zhou | Phase 4 |
| Recruiting | Efficacy and Safety of Madalena Association in the Treatment of Type II Diabetes Mellitus NCT04670666 | EMS | Phase 3 |
| Recruiting | Current Status of Islet Alpha Cell Function in Patients with Type 2 Diabetes NCT06825182 | Nanjing First Hospital, Nanjing Medical University | Phase 3 |
| Completed | A Study to Evaluate Pharmacokinetics of LY3209590 in Pediatric Participants With Type 2 Diabetes Mellitus NCT06362265 | Eli Lilly and Company | Phase 1 |
| Active Not Recruiting | An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic NCT06608212 | Bayer | — |
| Completed | Prolactin Levels in Type 2 Diabetic Patients With Stage III Periodontitis NCT06941246 | Faculty of Dental Medicine for Girls | N/A |
| Completed | Peau o le Vasa: Analysis of the Efficacy and Feasibility of the PILI Lifestyle Program (PLP) + Social Determin NCT06471595 | University of Hawaii | N/A |
| Recruiting | Efficacy and Safety of Pueraria Lobata Radix As an Adjuvant Treatment for Type 2 Diabetes Mellitus NCT06494683 | Jiangxi University of Traditional Chinese Medicine | N/A |
| Recruiting | Clinical Management of Cardiovascular Risk Factors in Adult Patients: A Before-and-After Interventional Study NCT07447362 | Universidad Católica San Antonio de Murcia | N/A |
| Completed | Turtle Therapy on HbA1c and Self-Efficacy Levels With Type 2 Diabetes NCT07298837 | Karadeniz Technical University | N/A |
| Withdrawn | A Study of Renal Autologous Cell Therapy (REACT) in Participants With Type 2 Diabetes and Chronic Kidney Disea NCT05286853 | Prokidney | Phase 3 |
| Active Not Recruiting | A Phase 3 Study to Evaluate the Efficacy of JY09 Compared With Placebo in T2DM Patients NCT06254014 | Beijing Dongfang Biotech Co., Ltd. | Phase 3 |
| Not Yet Recruiting | To Evaluate the Food Effect on Pharmacokinetic Profiles and Safety in Healthy Volunteers NCT06492655 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Not Yet Recruiting | Study on Drug Interaction of HRS-1780 Tablets, Henagliflozin Tablets, Metformin Tablets and HRS-7535 Tablets i NCT06495931 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Recruiting | Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM NCT06590519 | Universiti Putra Malaysia | N/A |
| Active Not Recruiting | Is the Degree of Perceived Effort During Resistance Exercise Important for Improvements in Blood Glucose NCT06208189 | University of New Mexico | N/A |
| Active Not Recruiting | Registry Study to Determine the Effectiveness and Safety of Weight Loss With Enavogliflozin in Patients With T NCT06427083 | Daewoong Pharmaceutical Co. LTD. | — |
| Completed | Comparative Study of Sitagliptin and Gliclazide With Metformin in Type 2 Diabetes Patients With Glucotoxicity NCT06613750 | Zhibin Xu | Phase 4 |
| Not Yet Recruiting | Research on Changes in Intestinal Barrier Function and Gut Microbiome in Patients With Type 2 Diabetes After D NCT06385704 | Wang Siqi | N/A |
| Completed | Preoperative Carbohydrate Loading in Diabetic Patients Undergoing Elective Abdominal Surgery NCT07451015 | Tanta University | N/A |
| Recruiting | A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy NCT06220773 | Boryung Pharmaceutical Co., Ltd | Phase 3 |
| Not Yet Recruiting | Bioavailability and Food Effects of HRS-7535 Tablets With Different Formulating Processes in Healthy Subjects NCT06422039 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Recruiting | An Observational Study Called FINEROD to Learn More About the Use of the Treatment Finerenone Including How Sa NCT06278207 | Bayer | — |
| Recruiting | Investigation of the Effect of Date Consumption on Hedonic Hunger and Appetite in Adult Individuals With Type NCT06826235 | Hacettepe University | N/A |
| Recruiting | Safety and Effectiveness of Endoscopic Intestinal Re-Cellularization Therapy in Individuals With Type II Diabe NCT06267391 | Endogenex, Inc. | N/A |
| Completed | A Study of TG103 Injection Monotherapy in Treatment of Type 2 Diabetes Mellitus NCT06258148 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Phase 3 |
| Completed | A Study of TG103 Injection Combined With Metformin in Treatment of Type 2 Diabetes Mellitus NCT06235086 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Phase 3 |
| Completed | Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic of CKD-501, D745, and D150 for Healthy S NCT06483243 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Unknown | Efficacy and Safety of Semaglutide Injection in Subjects With Type 2 Diabetes NCT06339086 | Chengdu Brilliant Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Effects of Henagliflozin on the Brain Function in T2DM Patients With Mild Cognitive Impairment: a Randomized, NCT06085703 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Unknown | Protocol for Alpha MSH Infusion Study in Patients With Type 2 Diabetes NCT06293664 | Dasman Diabetes Institute | N/A |
| Completed | A Study to Compare the Pharmacokinetics and the Safety Between a Fixed-dose Combination Administration of "BR3 NCT06289920 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Unknown | Safety and Efficacy of Human Microbiota Transplantation for Overweight and Obese Type 2 Diabetes Mellitus NCT05253768 | Zhujiang Hospital | Phase 2 |
| Completed | Efficacy and Safety of Semaglutide Injection (HD1916) in Patients With Type 2 Diabetes Mellitus NCT06161844 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Completed | A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1019" and Co-administration NCT06226727 | Boryung Pharmaceutical Co., Ltd | Phase 1 |
| Completed | ECC5004 DDI Study With Atorvastatin, Rosuvastatin, Digoxin and Midazolam in Healthy Participants NCT06293742 | Eccogene | Phase 1 |
| Completed | ECC5004 RBA FE Study in Healthy Participants NCT06268145 | Eccogene | Phase 1 |
| Completed | Effect of Using Bitter Melon, Blueberries and Cranberries on HbA1c and Diabetes Symptom Levels NCT07233460 | Hatice Demirağ, Ph.D | N/A |
| Completed | Disaster Preparedness in Patients With Diabetic Foot: The Effect of an Educational Intervention NCT07385833 | Senem Duman | N/A |
| Not Yet Recruiting | Efficacy and Safety of LID104 in the Treatment of Type II Diabetes Mellitus NCT05886088 | EMS | Phase 3 |
| Completed | Diabetes Self-Management Plus Tai Chi Easy NCT06180655 | University of Arizona | N/A |
| Recruiting | Effect of Mutations in T2DM Susceptibility Genes on the Expression of Susceptibility Genes in Patients With T2 NCT06277466 | The Affiliated Hospital of Xuzhou Medical University | N/A |
| Recruiting | Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS NCT06169033 | China-Japan Friendship Hospital | — |
| Completed | Effects of Olfactory Training on the Brain Function in T2DM Patients With Mild Cognitive Impairment NCT06327633 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Recruiting | Association of Gene Polymorphism With Susceptibility to T2DM and the Therapeutic Responses to Exenatide in Chi NCT06256419 | The Affiliated Hospital of Xuzhou Medical University | N/A |
| Completed | Assessment of Gastric Emptying by SHR20004 in Healthy Subjects NCT06137469 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Recruiting | PrevaLence of Albuminuria in Patients With CARdiovascular Disease and Type 2 Diabetes Mellitus in China: a Nat NCT06336239 | Beijing Anzhen Hospital | — |
| Completed | Application of a Protocol of Personalized Medicine in Patients With Type 2 Diabetes Mellitus and Multiple Dose NCT06148376 | Hospital Arnau de Vilanova | — |
| Completed | A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379 NCT06204107 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | A Study to Investigate the Safety and Tolerability of LY3938577 in Healthy Participants and Participants With NCT06132126 | Eli Lilly and Company | Phase 1 |
| Recruiting | Evaluation of the Effect of Finerenone on Renal Function in Patients With Type 2 Diabetes and Chronic Kidney D NCT06838416 | Second Affiliated Hospital of Soochow University | — |
| Completed | Efficacy and Safety of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Cont NCT06353347 | HighTide Biopharma Pty Ltd | Phase 3 |
| Recruiting | A Study of Glycemic Control in Left Ventricular Assist NCT05933161 | Mayo Clinic | — |
| Completed | Grocery Prescription Program for Medicaid Adults With Hypertension or Type 2 Diabetes NCT06033664 | Alison Gustafson | N/A |
| Unknown | Evaluation of Efficacy and Safety When Administered JP-2266 in Type 2 Diabetes Patients NCT06144788 | Jeil Pharmaceutical Co., Ltd. | Phase 2 |
| Unknown | Acetylcholine Iontophoresis As A New Challenge With Type 2 Diabetic Peripheral Neuropathy: A Possible New Ther NCT06219590 | South Valley University | N/A |
| Completed | Observational Study of Triple Combination Therapy of Zemidapa Tab. and Metformin in Type 2 Diabetes Mellitus P NCT06495281 | LG Chem | — |
| Completed | A Research Study to See How Well CagriSema Compared to Semaglutide, Cagrilintide and Placebo Lowers Blood Suga NCT06065540 | Novo Nordisk A/S | Phase 3 |
| Unknown | Relationship Between Nutritional Status, Hand Grip Strength, and Fatigue in Hospitalized Older Adults With Typ NCT06212778 | National Taiwan University Hospital | — |
| Completed | Fresh Carts for Mom's to Improve Food Security and Glucose Management NCT05979519 | Alison Gustafson | N/A |
| Unknown | Evaluation of Improved Outcomes Among Ambulatory Diabetes and/or Hypertensive Patients - an Intervention Study NCT05996601 | University of Ibadan | N/A |
| Completed | A Study Called SMART-Finder to Look for People With Increased Amounts of Albumin in the Urine (UACR Level) in NCT05552339 | Bayer | — |
| Completed | Effects of a Health Intervention on Hypoglycemic Coping : a Pilot Study NCT06384118 | Yating Liu | N/A |
| Completed | Intensive Aerobic and Resistance Exercise Program (IAREP) NCT06401733 | National University of Singapore | N/A |
| Completed | CGM Utilization With IV Insulin EndoTool and Subcutaneous Insulin in the Neuro ICU NCT05857007 | Wake Forest University Health Sciences | — |
| Active Not Recruiting | Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Metabolic Dysfunction-Associ NCT05067621 | Yale University | Phase 2 |
| Unknown | Glycemic Variability, Gut Microbiota, and Prognosis in T2DM With ACS NCT06573060 | Second Affiliated Hospital of Nanchang University | — |
| Recruiting | Prevalence, Incidence and Risk Signature of Chronic Kidney Disease in Sub-Saharan Africa NCT05881447 | Swiss Tropical & Public Health Institute | — |
| Completed | A SAD Study of ZT002 Injection in Healthy Participants NCT06423872 | Beijing QL Biopharmaceutical Co.,Ltd | Phase 1 |
| Unknown | the Relationship Between Executive Function and Diet Adherence in Patients With Type 2 Diabetes Mellitus NCT05841225 | Na Liu | N/A |
| Completed | An Observational Study Called FIRST-2.0 to Learn More About the Use of the Study Treatment Finerenone Includin NCT05703880 | Bayer | — |
| Unknown | The Impact of Frailty in Type 2 Diabetes NCT05863611 | Kırıkkale University | — |
| Completed | To Compare the Efficacy and Safety of INS068 and Insulin Glargine in Subjects With Type 2 Diabetes Mellitus Tr NCT05702073 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Completed | Safety and Efficacy of Insulin Degludec/Insulin Aspart in Patients With T2DM NCT05417841 | Beijing Hospital | N/A |
| Completed | An Intervention Study on the Effect of Brazilian Spinach Supplementation on Health Outcomes Among Type 2 Diabe NCT05727592 | Universiti Sains Malaysia | N/A |
| Recruiting | A Study to Investigate the Effect of DWP16001 as add-on Therapy to Drug A in Patients With Type 2 Diabetes Mel NCT05466643 | Daewoong Pharmaceutical Co. LTD. | Phase 3 |
| Recruiting | The Progress of Diabetes After Supaglutide Treatment in Type 2 Diabetes Patients NCT06605287 | Nanjing First Hospital, Nanjing Medical University | — |
| Unknown | Efficacy and Safety of Berlim 25/10 Association in the Treatment of Type II Diabetes Mellitus and Dyslipidemia NCT04603508 | EMS | Phase 3 |
| Unknown | Oral Health Policy for Patients With Type 2 Diabetes Mellitus in Chile: A Microsimulation Model Based on Real- NCT05809817 | University of Chile | — |
| Completed | A Randomized Controlled Trial to Compare the Glycemic Control, With or Without the Connected Solution, of Adul NCT05684341 | Sanofi | N/A |
| Completed | A Study to Learn How Safe the Study Drug Finerenone is and How Well it Works in Indian People With Long-term D NCT05705271 | Bayer | Phase 4 |
| Unknown | Association of Triglyceride Glucose Index and HOMA IR as Predictors of Vascular Complications of DM Type 2 NCT05695651 | Assiut University | — |
| Recruiting | The PRECISION II Study: Evaluating the Accuracy of the LabPatch Glucose Sensing System NCT05754281 | Joslin Diabetes Center | — |
| Completed | A Research Study to See How Well CagriSema Helps People With Type 2 Diabetes and Excess Body Weight Lose Weigh NCT05394519 | Novo Nordisk A/S | Phase 3 |
| Completed | Type 2 Diabetes Treatment and Remission With a Very Low-Calorie Ketogenic Diet (VLCKD) and Lifestyle Changes NCT05984459 | Cabinet Medical | — |
| Completed | Dose-ranging Study to Evaluate the Efficacy, Safety, and Tolerability of AMG 133 in Adult Subjects With Overwe NCT05669599 | Amgen | Phase 2 |
| Completed | To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With T2DM NCT05814406 | JW Pharmaceutical | Phase 3 |
| Completed | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM NCT05680129 | Hangzhou Sciwind Biosciences Co., Ltd. | Phase 3 |
| Completed | To Evaluate the Efficacy and Safety of JW0201 Added on in Patients With Type 2 Diabetes Mellitus NCT05814393 | JW Pharmaceutical | Phase 3 |
| Completed | The Impact of Ursodeoxycholic Acid and Probiotics on Metabolic Outcomes in Type 2 Diabetic Patients Taking Met NCT07072949 | University of Banja Luka | Phase 1 |
| Unknown | Mitochondrial DNA Copy Number and Leukocyte Telomere Length as Biomarkers in Type 2 Diabetic Patients NCT05684406 | Sohag University | — |
| Completed | A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients NCT05680155 | Hangzhou Sciwind Biosciences Co., Ltd. | Phase 3 |
| Unknown | Impact of Muscle and Tendon Dysfunction in People With Type 2 Diabetes Mellitus NCT05585502 | Universita di Verona | N/A |
| Terminated | Gla-300 and IDeg-100 in Insulin-Naïve People With Type 2 Diabetes Mellitus and Renal Impairment NCT05552859 | Sanofi | Phase 4 |
| Completed | FTIH of ECC5004 in Healthy and Diabetic Participants NCT05654831 | Eccogene | Phase 1 |
| Completed | Acute Effects of Cold-induced Shivering on 24-hour the Glucose Profile in Metabolically Compromised Population NCT05576025 | Maastricht University Medical Center | N/A |
| Completed | Real-life Efficacy of Insulia® Tool in Patients Living with Type 2 Diabetes Treated with Basal Insulin Therapy NCT05331339 | Centre Hospitalier Sud Francilien | — |
| Completed | A Study Using Surveys to Learn More About Treatment With Steroidal Mineralocorticoid Receptor Antagonists, How NCT05407662 | Bayer | — |
| Unknown | Establish Diagnostic Models Based on Olfactory Function and Odor-induced Brain Activation for Diabetes-Related NCT05543967 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | — |
| Active Not Recruiting | LIGHT-MCI Trial: GLP-1 Agonist, SGLT2 Inhibitor, and DPP-4 Inhibitor for MCI Remission in Type 2 Diabetes NCT05313529 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Completed | Mobile Technology and Motivational Interviewing in Type 2 Diabetes Patients NCT05919706 | Inonu University | N/A |
| Completed | An Observational Study, Called FINEGUST, to Learn More About How People With Chronic Kidney Disease and Type 2 NCT05526157 | Bayer | — |
| Completed | XW014 in Healthy Subjects and Patients With Type 2 Diabetes Mellitus (T2DM) NCT05579314 | Sciwind Biosciences USA Co., Ltd. | Phase 1 |
| Completed | A Study of ZT002 in Healthy Participants NCT05491421 | QL Biopharmaceutical Australia Pty Ltd | Phase 1 |
| Unknown | Efficacy and Safety Of Different Regimens In Patients With Type 2 Diabetes Receiving Intensive Insulin Therapy NCT05545800 | Xiangya Hospital of Central South University | Phase 3 |
| Unknown | Risk Model of Cognitive Impairment in Diabetes NCT05590442 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | — |
| Completed | Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D) NCT05731544 | Biomea Fusion Inc. | Phase 1 / Phase 2 |
| Completed | Value of Glycated Albumin in Intervention of Glycemic Control in Chinese Patients With Type 2 Diabetes NCT05227677 | Asahi Kasei Therapeutics Corporation | N/A |
| Unknown | The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin NCT05578352 | Nanjing First Hospital, Nanjing Medical University | N/A |
| Completed | Low-Calorie Diets on Type 2 Diabetes Remission NCT05472272 | Shanghai Municipal Hospital of Traditional Chinese Medicine | N/A |
| Completed | iGlarLixi vs IDegAsp in Chinese Participants After OAD(s) NCT05413369 | Sanofi | Phase 3 |
| Completed | Study of the Bioequivalence and Food Effects of HRX0701 Tablets in Healthy Subjects NCT05415644 | Shandong Suncadia Medicine Co., Ltd. | Phase 1 |
| Unknown | Stanford Kids CAMP Study NCT05380817 | Stanford University | N/A |
| Completed | A Study to Learn How Well the Treatment Combination of Finerenone and Empagliflozin Works and How Safe it is C NCT05254002 | Bayer | Phase 2 |
| Completed | Efficacy and Safety of HD-6277 in Adult Patients with Inadequate Control of Type 2 Diabetes Mellitus by Diet a NCT05666128 | Hyundai Pharm | Phase 2 |
| Unknown | A Study of TG103 Injection in Type 2 Diabetes Subjects NCT05348122 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Phase 2 |
| Active Not Recruiting | A Study Called FINE-REAL to Learn More About the Use of the Drug Finerenone in a Routine Medical Care Setting NCT05348733 | Bayer | — |
| Recruiting | Liver Fat as a Dietary Target of the Chinese Medical Nutrition Therapy (CMNT) Diet for Treating Type 2 Diabete NCT07083336 | State Key Laboratory of Subhealth Intervention Technology | N/A |
| Unknown | Association Between Time in Range and In-hospital Outcomes in Type 2 Diabetic Patients With Acute Coronary Syn NCT05389254 | Ningbo No. 1 Hospital | N/A |
| Unknown | The Effect of Metformin and DPP4 Inhibitors on Cognition and Cardiovascular Protection in Type 2 Diabetic Pati NCT05429554 | MTI University | — |
| Unknown | Study to Evaluate the Efficacy and Safety of PB-201 in Type 2 Diabetic Mellitus Patients With Poor Glycemic Co NCT05326490 | PegBio Co., Ltd. | Phase 3 |
| Completed | Accuracy of Dexcom G6® and FreeStyle Libre® Sensors in Standardized Hypoxemia Conditions NCT05144802 | Poitiers University Hospital | N/A |
| Completed | A Trial to Assess Steviol Glycosides on Acute Appetite Hormone Release NCT05287906 | Midwest Center for Metabolic and Cardiovascular Research | N/A |
| Completed | XW004 To Evaluate the Safety, Tolerability, PK, and PD of Oral Ecnoglutide Tablet in Healthy Adults NCT05184322 | Sciwind Biosciences APAC CO Pty. Ltd. | Phase 1 |
| Completed | First-in-human Single and Multiple Dose Trial of ATR-258 NCT05409924 | Atrogi AB | Phase 1 |
| Unknown | To Evaluate the Efficacy and Safety of JT-003 add-on in Patients With Type 2 Diabetes Mellitus Inadequately Co NCT05296044 | Jeil Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | A Phase 2 Study of Berberine Ursodeoxycholate (HTD1801) in Patients With Type 2 Diabetes Inadequately Controll NCT06411275 | HighTide Biopharma Pty Ltd | Phase 2 |
| Terminated | A Study of Oral GLP1RA RGT001-075 in Adults With Type 2 Diabetes NCT05297045 | Regor Pharmaceuticals Inc. | Phase 2 |
| Recruiting | Effects of Tirzepatide and Insulin Glargine on Glucolipid Metabolism and Brain Function in Patients With Type NCT05553093 | Nanjing First Hospital, Nanjing Medical University | Phase 4 |
| Unknown | Comparing the Efficacy of Mulberry Twig Alkaloid Tablet and Canagliflozin in Patients With Type 2 Diabetes NCT05856578 | Nanjing First Hospital, Nanjing Medical University | Phase 4 |
| Completed | A Study to Demonstrate Pharmacokinetic and Pharmacodynamic Biosimilarity Between HEC-Glargine and US-Lantus® i NCT05248841 | Lannett Company, Inc. | Phase 1 |
| Completed | BFR Walking for Insulin and Aerobic Improvement in Type 2 Diabetes NCT06290947 | Arab American University (Palestine) | N/A |
| Completed | Impact of Silymarin Adjunct Therapy on Proteinuria in Type 2 Diabetic Patients on RAS Inhibitors NCT06425705 | Lahore General Hospital | Phase 2 |
| Completed | A Study of CT-868 in Overweight and Obese Participants With Type 2 Diabetes Mellitus NCT05110846 | Carmot Therapeutics, Inc. | Phase 2 |
| Completed | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects NCT05497674 | Sunshine Lake Pharma Co., Ltd. | Phase 1 |
| Completed | Effect of Soliqua 100/33 on Time in Range From Continuous Glucose Monitoring in Insulin-naive Patients With Ve NCT05114590 | Sanofi | Phase 4 |
| Unknown | Effect of Insulin Staging in the Context of Pharmaceutical Care on Patients With Type 2 Diabetes Mellitus NCT05244200 | University of Sulaimani | N/A |
| Recruiting | Proact: A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease NCT05099770 | Prokidney | Phase 3 |
| Unknown | Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in Patients With Type 2 Diabetes NCT06281899 | Anemia Working Group Romania | Phase 4 |
| Completed | QTERN (SAXAGLIPTIN/DAPAGLIFLOZIN FDC) Regulatory Post-Marketing Surveillance NCT05160974 | AstraZeneca | — |
| Completed | A Single-dose and Multiple-dose Study to Evaluate the Pharmacokinetics and Pharmacodynamics of DBPR108 Tablets NCT05146869 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 1 |
| Completed | Study of Multiple Oral Doses of PF-07081532 in Adult Participants With Type 2 Diabetes Mellitus NCT05158244 | Pfizer | Phase 1 |
| Unknown | Effect of Probiotic Supplementation on Fecal Microbiota, Nutritional Status, Metabolic and Inflammatory Parame NCT05418179 | Universidade Federal de Santa Catarina | N/A |
| Unknown | To Evaluate the Efficacy and Safety of JT-001 add-on in Paatients With Type 2 Diabetes Mellitus Inadequately C NCT05101135 | Jeil Pharmaceutical Co., Ltd. | Phase 3 |
| Completed | Procedure for Duodenal-Ileal Diversion With a Sleeve Gastrectomy for Patients With Obesity and Type 2 Diabetes NCT04627103 | GI Windows, Inc. | N/A |
| Completed | Continuous Glucose Monitor Application After Hospital Discharge for the Improvement of Outcomes in Patients Wi NCT04938869 | Ohio State University Comprehensive Cancer Center | N/A |
| Unknown | A Study of TG103 Injection in Overweight/Obese Subjects With Type 2 Diabetes NCT05063253 | CSPC Baike (Shandong) Biopharmaceutical Co., Ltd. | Phase 2 |
| Recruiting | Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study) NCT05008276 | Petter Bjornstad | — |
| Completed | Pharmacokinetics of HR17031 Injection in Healthy Subjects NCT05031871 | Jiangsu HengRui Medicine Co., Ltd. | Phase 1 |
| Completed | Targeting Hyaluronan Accumulation Through Exercise in T2DM NCT04383314 | NYU Langone Health | N/A |
| Completed | An add-on Study to the FIGARO-DKD Study Called FIGARO-BM to Learn About the Link Between Biomarkers (Substance NCT05013008 | Bayer | Phase 2 |
| Completed | A Study to Learn More About Chronic Kidney Disease (CKD) in Patients With Type 2 Diabetes Mellitus (T2DM) NCT05004428 | Bayer | — |
| Completed | Effects of a Health Intervention on Fear of Hypoglycemia : a Pilot Study NCT06197360 | Yangzhou University | N/A |
| Completed | The Influence of Physical Activity on the Gut Microbiome of Pre-Diabetic Adults NCT04931836 | University of Minnesota | N/A |
| Completed | Renal Autologous Cell Therapy (REACT) in Subjects With Type 1 or 2 Diabetes and Chronic Kidney Disease (REGEN- NCT05018416 | Prokidney | Phase 2 |
| Completed | A Study of LY3209590 on Low Blood Sugar in Participants With Type 2 Diabetes Mellitus NCT04957914 | Eli Lilly and Company | Phase 1 |
| Completed | Effect of Tropicamide 0.5% vs Tropicamide 1% on Intraocular Pressure of Diabetic Patients NCT04932213 | Semnan University of Medical Sciences | Phase 3 |
| Unknown | Fasting and Postprandial Cerebral Blood Flow in Type 2 Diabetic Patients NCT04897815 | Qianfoshan Hospital | — |
| Completed | Comparison of Type 2 Diabetes Pharmacotherapy Regimens NCT05073692 | Kaiser Permanente | — |
| Unknown | Observational Study Gemigliptin in Patients Aged ≥ 65 Years With Type 2 Diabetes Mellitus NCT05281029 | LG Chem | — |
| Completed | Freestyle Libre-based Education on MDI in T2DM (FreEdoM-2) NCT04926623 | Daewoong Pharmaceutical Co. LTD. | N/A |
| Completed | Evaluation of the Safety and Efficacy of Insulin Glargine 300 U/ml (Gla-300) in Insulin-naïve Patients With Ty NCT04980027 | Sanofi | Phase 4 |
| Completed | Type 2 Diabetes Exemplar: A Remote Care Service for North West London NCT04731142 | Imperial College London | N/A |
| Completed | Evaluate the Drug-drugs Interaction Between Lobeglitazone 0.5mg and Empagliflozin 25mg NCT04869800 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Positive Effects of Daily Consumption of Bread Enriched With Hydroxytyrosol on the Results of a 12-week Dietar NCT04899791 | Harokopio University | N/A |
| Completed | A Clinical Efficacy and Safety Study of Insulin Glargine U300 in Chinese Adult Patients With Uncontrolled Type NCT05002933 | Sanofi | Phase 4 |
| Completed | Observational Study of ASCVD Risks of Type 2 Diabetes in East China NCT04866667 | Zhejiang Provincial People's Hospital | — |
| Completed | Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without NCT05411458 | Bozyaka Training and Research Hospital | N/A |
| Unknown | Effect of Time-restricted Eating on Blood Glucose and Behavior in Patients With Type 2 Diabetes Mellitus NCT04841837 | Peking University Third Hospital | N/A |
| Completed | Gut-Brain-axis: Targets for Improvement of Cognition in the Elderly NCT04841668 | Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta | — |
| Completed | To Assess Safety of Fixed Dose Combination of Dapagliflozin and Saxagliptin in Type 2 Diabetes Mellitus Patien NCT04445714 | AstraZeneca | Phase 4 |
| Completed | Effects of Moderate Physical Activity on Glycemic Control in Type 2 Diabetes Mellitus NCT04924777 | Riphah International University | N/A |
| Completed | The Effects of Pilates on Functional Capacity and Blood Glucose Levels in Adults With Diabetes Type 2 NCT05261776 | Riphah International University | N/A |
| Completed | Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus NCT05360147 | Third Military Medical University | Phase 3 |
| Unknown | COVID-19 Lockdown Related Telemedicine for Type 2 Diabetes NCT04723550 | Wenwen Yin | N/A |
| Terminated | In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part A NCT04650945 | University of Aarhus | N/A |
| Terminated | In-hospital Diabetes Management With Flash Glucose Monitoring (isCGM) - the INDIGO Study, Part B NCT04630925 | University of Aarhus | N/A |
| Completed | Role of Tele-physical Therapy in Patients With Type 2 Diabetes Mellitus Following COVID-19 Infection. NCT05599893 | Prince Sattam Bin Abdulaziz University | N/A |
| Completed | A Study to Learn More About How Acarbose and Metformin Work When Taken Together and How Safe They Are in India NCT04665570 | Bayer | — |
| Terminated | Study to Evaluate the Efficacy and Safety of ORMD-0801 in Subjects With Type 2 Diabetes Mellitus NCT04606576 | Oramed, Ltd. | Phase 3 |
| Completed | Renal Oxygenation, Oxygen Consumption and Hemodynamic Kinetics in Type 2 DIabetes: an Ertugliflozin Study. NCT04027530 | Amsterdam UMC, location VUmc | Phase 4 |
| Completed | A Study of Dulaglutide (LY2189265) in Chinese Participants With Type 2 Diabetes NCT04591626 | Eli Lilly and Company | Phase 3 |
| Completed | Omnipod® 5 Automated Insulin Delivery System in Patients With Type 2 Diabetes NCT04617795 | Insulet Corporation | N/A |
| Completed | A Study of LY3537021 in Healthy Participants and Participants With Type 2 Diabetes Mellitus NCT04586907 | Eli Lilly and Company | Phase 1 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese NCT04552470 | Pfizer | Phase 1 |
| Unknown | DEMAND - Multifactorial Study to Reduce Dementia in People With Type 2 Diabetes NCT03877783 | Umeå University | N/A |
| Completed | Fasting-Associated Immune-metabolic Remission of Diabetes NCT05295160 | Charite University, Berlin, Germany | N/A |
| Completed | Distal Renal Denervation to Prevent Renal Function Decline in Patients With T2DM and Hypertension NCT04948918 | Tomsk National Research Medical Center of the Russian Academy of Sciences | N/A |
| Completed | The Effects of Semaglutide vs Testosterone Replacement Therapy on Functional Hypogonadism and Sperm Quality in NCT06489457 | University Medical Centre Ljubljana | Phase 3 |
| Completed | Pharmacokinetic Drug Interaction Between Teneligliptin and Empagliflozin NCT04431141 | Handok Inc. | Phase 1 |
| Completed | Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System NCT04529239 | Klick Inc. | — |
| Completed | A Study of Cotadutide in Participants Who Have Chronic Kidney Disease With Type 2 Diabetes Mellitus NCT04515849 | AstraZeneca | Phase 2 |
| Completed | The Effects of Nutritional Intervention on Health Parameters in Participants With Type 2 Diabetes Mellitus NCT06235762 | Sao Jose do Rio Preto Medical School | N/A |
| Completed | Evaluation of Updated Continuous Glucose Monitoring (CGM) Form Factor in Adults, Adolescents and Pediatrics NCT04436822 | Medtronic MiniMed, Inc. | N/A |
| Completed | A Randomized, Placebo-controlled Clinical Trial of Teneligliptin as Quadruple Oral Combination Therapy for Typ NCT04446026 | Yonsei University | Phase 4 |
| Completed | Evaluation of the Relationship Between Missed Appointments and Adherence to Medical Indications NCT06501456 | Hospital Italiano de Buenos Aires | — |
| Completed | A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus NCT04450394 | Eli Lilly and Company | Phase 2 |
| Completed | Study of a High-Dose Aflibercept in Participants With Diabetic Eye Disease NCT04429503 | Regeneron Pharmaceuticals | Phase 2 / Phase 3 |
| Completed | Multiple Ascending Doses of SY-008 in Type 2 Diabetes Mellitus NCT04345120 | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Phase 1 |
| Completed | A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction and Safety of CKD-501, D759 and D150 (CKD NCT04431687 | Chong Kun Dang Pharmaceutical | Phase 1 |
| Completed | Antimicrobial Photodynamic Therapy in Chronic Periodontitis and Diabetes Mellitus NCT04857346 | King Saud University | Phase 2 / Phase 3 |
| Completed | HOME COOKING: Health Empowerment Strategy in People With Type II Diabetes Mellitus NCT04449120 | Basque Culinary Center Fundazioa | N/A |
| Completed | A Study of Tirzepatide (LY3298176) Compared With Dulaglutide on Major Cardiovascular Events in Participants Wi NCT04255433 | Eli Lilly and Company | Phase 3 |
| Unknown | Efficacy and Safety of iGlarLixi Versus Insulin Glargine Plus Dulaglutide in Patients With Type 2 Diabetes NCT04893148 | Chungbuk National University Hospital | Phase 4 |
| Completed | Impact of Acetaminophen on Performance of Guardian™ Sensor (3) in Adults NCT04378114 | Medtronic MiniMed, Inc. | N/A |
| Completed | Harmonizing RCT-Duplicate Emulations In A Real World Replication Program (HARRP) NCT06099067 | AstraZeneca | — |
| Unknown | Efficacy Comparison of Polyethylene Glycol Loxenatide and Gliclazide on the Brain Function in T2DM Patients NCT06217887 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Completed | Multiple Ascending Doses of SY-009 in Type 2 Diabetes Mellitus NCT04345107 | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Phase 1 |
| Completed | To Evaluate the Safety, Tolerability, PK, and PD of XW003 Injection in Healthy Adult Participants NCT04389775 | Sciwind Biosciences APAC CO Pty. Ltd. | Phase 1 |
| Completed | Specified Drug-Use Survey of Trelagliptin Tablets "Survey on Long-term Use in Type 2 Diabetes Mellitus Patient NCT04285983 | Takeda | — |
| Completed | A Study of DBPR108 and Metformin Hydrochloride Combination Therapy in Patients With T2DM NCT04218734 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Completed | A Study to Evaluate the Efficacy and Safety of DBPR108 100 mg in Type 2 Diabetes Mellitus Patients NCT04161430 | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Phase 3 |
| Unknown | Effectiveness of Shared Care Diabetes Management in Patients With Type 2 Diabetes NCT04100278 | Beijing Chao Yang Hospital | N/A |
| Unknown | Study of TQ-F3083 Capsules in Subjects With Type 2 Diabetes Mellitus NCT03986073 | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Phase 2 |
| Unknown | Uric Acid Lowering Trial in Youth Onset T2D NCT03899883 | University of Colorado, Denver | Phase 2 |
| Completed | A Study of Insulin Glargine (LY2963016) in Adult Participants With Type 2 Diabetes in India NCT04153981 | Eli Lilly and Company | Phase 4 |
| Completed | The Efficacy and Safety of Different Doses of SY-004 in Patients With Type 2 Diabetes Mellitus NCT04217291 | Suzhou Yabao Pharmaceutical R&D Co., Ltd. | Phase 2 |
| Unknown | Dapagliflozin vs Empagliflozin on Flow Mediated Dilation in Type 2 Diabetes Mellitus NCT04195243 | Centro Universitario de Ciencias de la Salud, Mexico | Phase 3 |
| Unknown | Preliminary Exploration on the Operational Standards of Insulin Pump Installation in Diabetes Clinic in China NCT04129424 | Peking Union Medical College Hospital | N/A |
| Completed | Effect of Pre-meal Serving of Dairy and Dairy Alternatives on Post-meal Satiety and Glycaemia in Healthy Young NCT04600128 | University of Toronto | N/A |
| Unknown | Effect of Dihydromirycetin on Glycemic Control, Insulin Sensitivity and Insulin Secretion in Type 2 Diabetes M NCT03606694 | University of Guadalajara | Phase 2 |
| Completed | Ertugliflozin Type 2 Diabetes Mellitus (T2DM) Pediatric Study (MK-8835/PF-04971729) (MK-8835-059) NCT04029480 | Merck Sharp & Dohme LLC | Phase 3 |
| Unknown | Therapeutic Effect of Dapagliflozin Combined With CSII on Newly Diagnosed Type 2 Diabetes Mellitus NCT04120623 | Nanjing First Hospital, Nanjing Medical University | Phase 4 |
| Active Not Recruiting | Testosterone Therapy and Bone Quality in Men With Diabetes and Hypogonadism NCT03887936 | VA Office of Research and Development | Phase 4 |
| Completed | Diabetes Management Program for Hispanic/Latino NCT03960424 | Northwell Health | N/A |
| Completed | A Study Investigating the Pharmacokinetics of a Single Dose Administration of Cotadutide NCT04091373 | MedImmune LLC | Phase 1 |
| Completed | Metabolic Effects of Melatonin Treatment NCT03859934 | University of Aarhus | Phase 1 |
| Unknown | The MILESTONE Study NCT04086043 | Zhongda Hospital | N/A |
| Unknown | Effects of SGLT2 Inhibitors on Islet Cell Function and Insulin Sensitivity in Patients of Type 2 Diabetes Mell NCT04014192 | Peking Union Medical College Hospital | Phase 4 |
| Completed | Women and Risk of Type 2 Diabetes NCT03870724 | University of Oslo | — |
| Completed | A Study to Evaluate the DDI of HSK7653 With Metformin NCT06084156 | Haisco Pharmaceutical Group Co., Ltd. | Phase 1 |
| Terminated | Placebo-Controlled Clinical Nutrition Study of the Metabolic Effects of Food Product WBF-0011 in Type 2 Diabet NCT04047537 | Pendulum Therapeutics | N/A |
| Completed | Quadruple Oral Combination Therapy for Type 2 Diabetes Mellitus : Glycemic Control by Thiazolidinedione (TZD) NCT04013581 | Yonsei University | Phase 4 |
| Unknown | Development of Diabetes Mobile Application NCT04686201 | National University of Malaysia | Phase 3 |
| Completed | The Application and Evaluation of eHealth Literacy (eHL) Concept NCT05180604 | National Yang Ming Chiao Tung University | N/A |
| Terminated | Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Con NCT03770728 | Sanofi | Phase 3 |
| Completed | An Ascending Dose, Single/Multiple Dosing, Food Effect Clinical Trial to Evaluate Pharmacokinetics, Safety and NCT03864432 | LG Chem | Phase 1 |
| Completed | Efficacy and Safety of Alogliptin vs. Acarbose in Chinese Type 2 Diabetes Mellitus (T2DM) Patients With High C NCT03794336 | Sanofi | Phase 4 |
| Unknown | Liraglutide in Acute Minor Ischemic Stroke or High-risk Transient Ischemic Attack Patients With Type 2 Diabete NCT03948347 | First Affiliated Hospital of Jinan University | N/A |
| Completed | Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus NCT06061510 | Southeast University, China | N/A |
| Completed | A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise NCT03954834 | Eli Lilly and Company | Phase 3 |
| Unknown | A Phase 2, 12-Week, Double-Blind, Efficacy and Safety of GX-G6 in Patients With Uncontrolled Type 2 Diabetes M NCT03962010 | Genexine, Inc. | Phase 2 |
| Unknown | Effects of Short-term Intensive Insulin Therapy on Long-term Complications in Type 2 Diabetes NCT03909555 | Sun Yat-sen University | — |
| Completed | A Study of LY900014 Compared to Insulin Lispro (Humalog) in Adults With Type 2 Diabetes NCT03952143 | Eli Lilly and Company | Phase 3 |
| Completed | Effects of Mulberry Leaves on Glycemic Control in Patients With Obesity and Patients With Type 2 Diabetes NCT04691219 | Chulalongkorn University | N/A |
| Withdrawn | Assessment of the Safety and Effect of SAR425899 Versus Placebo for the Treatment of Non-alcoholic Fatty Liver NCT03437720 | Sanofi | Phase 2 |
| Completed | Face-it: Health Promotion for Women With Prior Gestational Diabetes NCT03997773 | Steno Diabetes Center Copenhagen | N/A |
| Completed | SGLT-2 Inhibition, Metabolomics and Cardiovascular/Kidney Disease NCT03919656 | Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud | Phase 4 |
| Unknown | Cadence and Intensity in Adults With Type 2 Diabetes NCT03940937 | University of Massachusetts, Amherst | — |
| Unknown | Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-indu NCT03961659 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | N/A |
| Unknown | Acute Mycoprotein Effect on Glycaemic Control in South Asians NCT03949582 | Imperial College London | N/A |
| Completed | Immunometabolism in Pediatric Obesity NCT03960333 | Arkansas Children's Hospital Research Institute | — |
| Unknown | BM-MNCs and UC-MSCs Infusion for Type 2 Diabetes Mellitus Patients NCT03943940 | Van Hanh General Hospital | Phase 1 / Phase 2 |
| Completed | A Clinical Study to Access the Pharmacokinetics of HMS5552 in Renal Impaired Subjects and Healthy Volunteers NCT04324424 | Hua Medicine Limited | Phase 1 |
| Completed | Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IDegLira NCT03862716 | Population Health Research Institute | Phase 3 |